QIAGEN

QIAGEN是一家荷兰上市公司，是全球领先的样本制备和分析技术的供应商。样品制备技术用来分离和处理从血液或组织等样品中提取的DNA、RNA和蛋白，而分析技术使这些分离的分子可被检测，便于生物学研究和疾病检测。QIAGEN已经开发了500多种全面的产品组合，包括试剂和自动化解决方案。QIAGEN产品的主要客户包括分子诊断实验室、学术研究领域，制药和生物技术公司，应用检测用户（例如法医鉴定，动物和食品检测，以及药物过程控制等）。QIAGEN的分析技术涵盖最广泛的分子诊断产品，包括在检测宫颈癌主要病因高危型HPV中被称为"金标准"的HPV检测试剂以及在传染疾病和伴随诊断中广泛应用的配套试剂。截止2011年12月31日，QIAGEN在全球超过35个城市拥有3900多名员工。

QIAGEN是一家专业化致力于生物分子样品制备解决方案的跨国经营企业，总部位于德国。1984年，QIAGEN在德国成立，1996年在美国纽约纳斯达克上市。QIAGEN在全球有亚太、日本、北美、欧洲四个地区总部，有19个分公司，有近2,000雇员，有超过500个的产品，有超过40万的用户，拥有409个已被批准的专利，有300多种专利正在申请之中。成立20多年来，QIAGEN发展迅速，取得了不俗的业绩，近10年中，每年的平均销售增长在25%，利润的增长平均在33%左右。2005年，QIAGEN的销售达到4亿美元，2006年将达到4.5亿美元，2007年估计将达到5.2亿美元，是在生命科学研究、应用检测和临床诊断等领域的行业巨头。

QIAGEN拥有超过1000项专利和认可证明，在18个国家设立了分公司，代理商服务国超过40个，在全球有超过400000的用户。Qiagen提供的产品超过500类，包括各种试剂，耗材和自动化纯化工作站。这些产品用于样品采集，稳定，核酸或蛋白的分离，纯化和检测中，不仅广泛的应用于科研领域的各个方面，在生物技术，制药，法医研究，食品安全检测，畜牧业和分子诊断领域也得到了广泛的应用。Qiagen产品的卓越品质和在应用中的出色表现使得我们成为样品处理中标准的代名词。

Qiagen, a Dutch listed company, is the world's leading supplier of sample preparation and analysis technology. Sample preparation technology is used to separate and process DNA, RNA and proteins extracted from blood or tissue samples, and analysis technology makes these separated molecules detectable for biological research and disease detection. Qiagen has developed more than 500 comprehensive product portfolios, including reagents and automation solutions. Qiagen's main customers include molecular diagnostic laboratories, academic research fields, pharmaceutical and biotechnology companies, and application testing users (such as forensic identification, animal and food testing, and drug process control).

Qiagen's analytical technology covers the widest range of molecular diagnostic products, including HPV detection reagents known as the "gold standard" in the detection of high-risk HPV, the main etiology of cervical cancer, and supporting reagents widely used in infectious diseases and concomitant diagnosis. As of December 31, 2011, Qiagen has more than 3900 employees in more than 35 cities around the world.

Qiagen is a multinational enterprise specializing in biomolecular sample preparation solutions, headquartered in Germany. Qiagen was founded in Germany in 1984 and listed on NASDAQ in New York in 1996. Qiagen has four regional headquarters in Asia Pacific, Japan, North America and Europe, 19 branches, nearly 2000 employees, more than 500 products, more than 400000 users, 409 approved patents and more than 300 patents under application. Since its establishment for more than 20 years, Qiagen has developed rapidly and achieved good performance. In recent 10 years, the average annual sales growth is 25% and the average profit growth is about 33%. Qiagen's sales reached US $400 million in 2005, US $450 million in 2006 and US $520 million in 2007. Qiagen is an industry giant in the fields of life science research, applied testing and clinical diagnosis.

Qiagen has more than 1000 patents and recognition certificates, has set up branches in 18 countries, has more than 40 agent service countries, and has more than 400000 users worldwide. Qiagen provides more than 500 kinds of products, including various reagents, consumables and automatic purification workstations. These products are used in sample collection, stabilization, separation, purification and detection of nucleic acid or protein. They are not only widely used in all aspects of scientific research, but also widely used in biotechnology, pharmacy, forensic research, food safety detection, animal husbandry and molecular diagnosis. Qiagen's excellent quality and excellent performance in application make us synonymous with the standard in sample processing.